GHK-CU 1mg – 30mL Nasal

Introduction to GHK-CU 1mg Nasal Format for Research Use

GHK-CU 1mg in a 30mL nasal formulation is a research-grade compound supplied exclusively for laboratory and experimental applications. This product is designed to support scientific investigations requiring a stable, precisely quantified source of GHK-CU in a nasal delivery medium. The primary keyword “GHK-CU nasal research compound” is integrated naturally throughout this description to optimize search relevance.

Scientific and Research Context of GHK-CU

GHK-CU, a copper peptide complex, is characterized by its defined tripeptide structure bound to copper ions, making it a subject of interest in biochemical and molecular research. Within research environments, GHK-CU serves as a model compound for studying peptide-metal interactions, cellular signaling pathways, and biochemical modulation mechanisms. Its well-documented physicochemical properties facilitate its use in controlled laboratory experiments without implying any clinical or therapeutic application.

Laboratory Applications of GHK-CU Nasal Format

In research settings, GHK-CU nasal formulation is utilized primarily in analytical studies, receptor binding assays, and experimental modeling of peptide delivery systems. The nasal format allows for investigations into compound stability, delivery kinetics, and interaction with mucosal tissues under controlled conditions. Researchers employ this compound in non-clinical frameworks such as in vitro assays, ex vivo tissue studies, and biochemical pathway analysis.

Product Specifications

• Strength: 1mg per mL concentration
• Format: Nasal solution
• Quantity: 30mL per unit
• Storage Conditions: Recommended storage at 2–8°C, protected from light to maintain compound integrity
• Handling Details: Use appropriate laboratory safety protocols, including gloves and eye protection; avoid contamination
• Batch and Quality Control: Supplied with batch-specific documentation ensuring consistent quality and traceability

Handling and Laboratory Protocol Notes

GHK-CU nasal solution demonstrates stability under refrigerated conditions for the duration specified on the batch certificate. Researchers should handle the compound using aseptic techniques to prevent degradation or contamination. Preparation for experimental use involves precise aliquoting and may require dilution or formulation adjustments depending on the study design.

Key Features

• Research-grade GHK-CU supplied in a nasal solution format
• 1mg/mL concentration ensuring precise dosing for experimental protocols
• 30mL volume suitable for multiple laboratory assays
• Batch-controlled quality with documentation for reproducibility
• Storage recommendations to preserve compound stability
• Strictly for non-clinical, research use only

Related Research Areas

GHK-CU is often studied alongside other copper-binding peptides and research peptides within the broader category of biochemical modulators. Adjacent compounds include metallopeptides, peptide analogs, and synthetic peptides used in molecular biology, biochemistry, and pharmacological research frameworks. These categories support comprehensive experimental designs involving peptide-metal interactions and delivery system evaluations.

Conclusion

GHK-CU 1mg nasal solution from Axiocent represents a reliable and well-characterized research compound tailored for laboratory investigations. Its consistent quality, documented batch control, and specialized formulation support rigorous scientific inquiry within non-clinical research domains.

Compliance Disclaimer

For research use only. Not for human or veterinary use. Not intended for medical, therapeutic, or diagnostic purposes.